Digital Health Exit Transactions H1 2023

With strong geopolitical and economic headwinds impacting investor appetite, Exit deals has continued to decrease as compared to previous years. Here are the exit deals that has occurred in H1 2023. For a complete analysis of Global Exit Deals, download your own copy of Galen Growth’s H1 2023 Global Report from https://www.healthtechalpha.com/research/global-digital-health-ecosystem-2023-mid-year-report .

Last Updated: February 06, 2025

Ventures

Venture	Primary Category	Country	Therapeutic Focus	Valuation	Stage	Current Funding
98point6	Teleconsultation	United States	$ 123.46 B	$ 123.46 B	M&A	$ 100.00 M
Alchemy	Online Pharmacy	Bangladesh	$ 123.46 B	$ 123.46 B	M&A	undisclosed
Amelia Virtual Care	Digital Therapeutics	Spain	$ 123.46 B	$ 123.46 B	M&A	undisclosed
Apixio	Prescriptive Analytics	United States	$ 123.46 B	$ 123.46 B	M&A	undisclosed
Arkan United	Teleradiology	Saudi Arabia	$ 123.46 B	$ 123.46 B	M&A	undisclosed
Augmedix	EHR / PHR	United States	$ 123.46 B	$ 123.46 B	Post-IPO Equity	$ 12.00 M
Berg Health	Drug Discovery	United States	$ 123.46 B	$ 123.46 B	M&A	undisclosed
Biomaneo	Bioinformatics	France	$ 123.46 B	$ 123.46 B	M&A	undisclosed
BioSig Technologies	Software Provider	United States	$ 123.46 B	$ 123.46 B	Post-IPO Equity	$ 10.17 M
BioSig Technologies	Software Provider	United States	$ 123.46 B	$ 123.46 B	Post-IPO Equity	$ 6.58 M

Showing 1 to 10 of 115 entries